AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gliminac M 3mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

NACC Pharmaceutical Pvt Ltd

Salt Composition

Glimepiride (3mg) + Metformin (500mg)

Overview Gliminac M 3mg/500mg Tablet

Diabetic patients using Glucovance-equivalent medication (3mg/500mg tablet formulation) manage type 2 diabetes through this anti-diabetic combination therapy. This dual-action medication effectively regulates blood glucose in adult patients. Administer this medication with food, consistently at the same time daily for optimal results. Dosage is determined by your physician and may be adjusted based on your blood glucose response. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to complications such as renal impairment, vision loss, neuropathy, and limb amputation. This medication is only one component of a comprehensive diabetes management plan that includes a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Prompt treatment with fast-acting glucose (e.g., sugary foods or juice) is essential; always carry a readily available source. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain is also a possibility. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before initiating treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests (blood cell counts and liver function) are recommended.

Uses of Gliminac M 3mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Gliminac M 3mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the advised dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Gliminac M 3mg/500mg Tablet should be administered with a meal.

Common Side effects of Gliminac M 3mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Gliminac M 3mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Gliminac M 3mg/500mg tablets should be administered with food.

How Gliminac M 3mg/500mg Tablet works:

Gliminac M 3mg/500mg tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Gliminac M 3mg/500mg Tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Gliminac M 3mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Gliminac M 3mg/500mg tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Gliminac M 3mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. This medication is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

For individuals with liver impairment, Gliminac M 3mg/500mg tablets require careful administration. Dosage modification may be necessary. Physician consultation is advised. In those with mild to moderate liver disease, treatment typically begins with a low Gliminac M 3mg/500mg tablet dose; however, its use is contraindicated in patients exhibiting severe hepatic dysfunction.

What if you forget to take Gliminac M 3mg/500mg Tablet :

Should you forget a Gliminac M 3mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gliminac M 3mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Gliminac M 3mg/500mg Tablet

Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Gliminac M 3mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency involving high blood lactic acid levels. This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Gliminac M 3mg/500mg Tablets and seek immediate medical attention.
Gliminac M 3mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Gliminac M 3mg/500mg Tablets may cause common side effects such as hypoglycemia (low blood sugar), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Prolonged Gliminac M 3mg/500mg Tablet use can lead to vitamin B12 deficiency by impairing its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and altered mental status. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Gliminac M 3mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with skipped meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Gliminac M 3mg/500mg tablets with alcohol is unsafe. Alcohol can exacerbate the drug's effect, potentially causing dangerously low blood sugar (hypoglycemia) and increasing the risk of lactic acidosis.
Gliminac M 3mg/500mg Tabl...
78
MRP 95
17% off